Trial Profile

Clinical Trials Insight: 700037565

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 29 Apr 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Glatiramer acetate (Primary)
Indications Multiple sclerosis
Focus Therapeutic Use
Sponsors Teva Pharmaceutical Industries

Most Recent Events

26 Feb 2010 15-year results were published in Multiple Sclerosis, according to a Teva Pharmaceuticals media release.
12 Sep 2009 Interim results preseneted at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
11 Sep 2009 Teva Pharmaceuticals report that results will be presented at ECTRIMS 2009.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com